| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $42.0M | -12.3% |
| SG&A Expense | $17.3M | +7.6% |
| Operating Income | -$59.4M | +7.3% |
| Income Tax | $0 | — |
| Net Income | -$56.0M | +8.2% |
| EPS (Basic) | -$1.27 | +37.7% |
| EPS (Diluted) | -$1.27 | +37.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $128.6M | +255.9% |
| Current Assets | $176.2M | +345.2% |
| Total Assets | $232.0M | +340.1% |
| Current Liabilities | $10.1M | +34.2% |
| Total Liabilities | $13.5M | +19.2% |
| Stockholders' Equity | $218.5M | +427.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$45.3M | +17.6% |
| Capital Expenditures | $142K | +67.6% |
| Investing Cash Flow | -$88.7M | -435.7% |
| Financing Cash Flow | $226.6M | +4172.3% |
| Free Cash Flow | -$45.5M | +17.4% |